MetaADEDB 2.0 @ LMMD
Metronidazole
(VAOCPAMSLUNLGC-UHFFFAOYSA-N)
Structure
SMILES
OCCn1c(C)ncc1[N+](=O)[O-]
Type(s)
Approved
ATC code(s)
A01AB17; A02BD01; A02BD02; A02BD03; A02BD08; A02BD11; D06BX01; G01AF01; G01AF20; J01RA03; J01RA04; J01RA10; J01XD01; P01AB01; P01AB51
Molecular Formula:
C6H9N3O3
Molecular Weight:
171.154
Log P:
0.6152
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
1
TPSA:
83.87
CAS Number(s):
443-48-1; 99616-64-5
Synonym(s)
1.
Metronidazole
2.
2-Methyl-5-nitroimidazole-1-ethanol
3.
Bayer 5360
4.
Clont
5.
Danizol
6.
Flagyl
7.
Gineflavir
8.
Metric
9.
MetroGel
10.
Metrodzhil
11.
Metrogyl
12.
Metronidazole Hydrochloride
13.
Metronidazole Monohydrochloride
14.
Metronidazole Phosphate
15.
Metronidazole Phosphoester
16.
Satric
17.
Trichazol
18.
Trichopol
19.
Trivazol
20.
Vagilen
21.
2 Methyl 5 nitroimidazole 1 ethanol
External Link(s)
MeSHD008795
PubChem Compound4173
BindingDB50375309
ChEBI6909
CHEMBLCHEMBL137
DrugBankDB00916
DrugCentral1790
KEGGcpd:C07203
dr:D00409
Therapeutic Target DatabaseD0A2ZX
ZINC113442
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 310
Canada Vigilance: 58

View details

CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
2DizzinessFAERS: 224
Canada Vigilance: 34
11098341CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
3VomitingFAERS: 221
Canada Vigilance: 21
4603136CTD
SIDER
Canada Vigilance
US FAERS
4HeadacheFAERS: 210
Canada Vigilance: 28
Canada Vigilance
SIDER
US FAERS
5Drug ineffectiveFAERS: 181
Canada Vigilance: 98
Canada Vigilance
US FAERS
6DysarthriaFAERS: 155
Canada Vigilance: 13

View details

CTD
SIDER
Canada Vigilance
US FAERS
7UrticariaFAERS: 131
Canada Vigilance: 21
11792017CTD
SIDER
Canada Vigilance
US FAERS
8DysgeusiaFAERS: 116
Canada Vigilance: 13
Canada Vigilance
SIDER
US FAERS
9PruritusFAERS: 116
Canada Vigilance: 19
Canada Vigilance
SIDER
US FAERS
10MalaiseFAERS: 112
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
11AtaxiaFAERS: 109
Canada Vigilance: 20

View details

CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
12Toxicity to various agentsFAERS: 90
Canada Vigilance: 9
Canada Vigilance
US FAERS
13FatigueFAERS: 88
Canada Vigilance: 12
Canada Vigilance
SIDER
US FAERS
14HypersensitivityFAERS: 73
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
15AnxietyFAERS: 72
Canada Vigilance: 6
Canada Vigilance
OFFSIDES
US FAERS
16PainFAERS: 63
Canada Vigilance: 8
3025992CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
17ErythemaFAERS: 62
Canada Vigilance: 18
Canada Vigilance
SIDER
US FAERS
18SomnolenceFAERS: 58
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
19AstheniaFAERS: 57
Canada Vigilance: 11
Canada Vigilance
OFFSIDES
SIDER
US FAERS
20VertigoFAERS: 54
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
21Abdominal discomfortFAERS: 52
Canada Vigilance: 7
Canada Vigilance
OFFSIDES
SIDER
US FAERS
22TremorFAERS: 51
Canada Vigilance: 6
11528241
16145214
CTD
SIDER
Canada Vigilance
US FAERS
23ArthralgiaFAERS: 50SIDER
US FAERS
24Musculoskeletal stiffnessFAERS: 50
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
25Feeling abnormalFAERS: 49
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
26ChromaturiaFAERS: 47
Canada Vigilance: 11
Canada Vigilance
OFFSIDES
US FAERS
27MyalgiaFAERS: 44
Canada Vigilance: 4
Canada Vigilance
US FAERS
28Burning sensationFAERS: 43
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
29nervous system disorderFAERS: 43SIDER
US FAERS
30Abdominal PainFAERS: 39
Canada Vigilance: 6
2306432
9317068
17061489
CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
31PalpitationsFAERS: 37
Canada Vigilance: 9
Canada Vigilance
SIDER
US FAERS
32Mental status changesFAERS: 33OFFSIDES
US FAERS
33SwellingFAERS: 33
Canada Vigilance: 2
Canada Vigilance
US FAERS
34Weight decreasedFAERS: 33
Canada Vigilance: 3
Canada Vigilance
US FAERS
35Cerebellar AtaxiaFAERS: 30
Canada Vigilance: 1

View details

CTD
Canada Vigilance
US FAERS
36NystagmusFAERS: 30SIDER
US FAERS
37Chest PainFAERS: 28
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
38ChillsFAERS: 28
Canada Vigilance: 7
Canada Vigilance
US FAERS
39Drug exposure during pregnancyFAERS: 28US FAERS
40Central nervous system lesionFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
41RosaceaFAERS: 27
Canada Vigilance: 8

View details

CTD
SIDER
Canada Vigilance
US FAERS
42TinnitusFAERS: 27
Canada Vigilance: 3
7986915
10474673
CTD
SIDER
Canada Vigilance
US FAERS
43Eye painFAERS: 26
Canada Vigilance: 3
Canada Vigilance
US FAERS
44Product use issueFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
45Visual ImpairmentFAERS: 24
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
46AngioedemaFAERS: 23
Canada Vigilance: 3
636588CTD
SIDER
Canada Vigilance
US FAERS
47DisorientationFAERS: 23
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
48Product taste abnormalFAERS: 23US FAERS
49treatment failureFAERS: 23
Canada Vigilance: 2
Canada Vigilance
US FAERS
50Lip swellingFAERS: 22US FAERS
51PancreatitisFAERS: 2210484002CTD
SIDER
US FAERS
52SyncopeFAERS: 22
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
53Oropharyngeal painFAERS: 21
Canada Vigilance: 2
Canada Vigilance
US FAERS
54AphasiaFAERS: 20US FAERS
55ShockFAERS: 20SIDER
US FAERS
56Back PainFAERS: 19
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
57Cerebrovascular accidentFAERS: 19US FAERS
58HemiparesisFAERS: 19US FAERS
59HypotensionFAERS: 19US FAERS
60Anaphylactic shockFAERS: 18SIDER
US FAERS
61ConstipationFAERS: 18
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
62Product quality issueFAERS: 18
Canada Vigilance: 4
Canada Vigilance
US FAERS
63Drug ineffective for unapproved indicationFAERS: 17US FAERS
64DyspepsiaFAERS: 17
Canada Vigilance: 4
17316343CTD
SIDER
Canada Vigilance
US FAERS
65Neck PainFAERS: 17
Canada Vigilance: 5
Canada Vigilance
US FAERS
66No adverse eventFAERS: 17US FAERS
67Clostridium difficile infectionFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
68DiplopiaFAERS: 16SIDER
US FAERS
69Peripheral swellingFAERS: 16
Canada Vigilance: 3
Canada Vigilance
US FAERS
70PolyneuropathyFAERS: 16
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
71AbasiaFAERS: 15US FAERS
72BlindnessFAERS: 15US FAERS
73Chest discomfortFAERS: 15US FAERS
74DysuriaFAERS: 15
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
75FlushingFAERS: 15
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
76Joint swellingFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
77LethargyFAERS: 15
Canada Vigilance: 3
Canada Vigilance
US FAERS
78PhotophobiaFAERS: 15US FAERS
79AgitationFAERS: 14
Canada Vigilance: 3
Canada Vigilance
US FAERS
80Expired product administeredFAERS: 14US FAERS
81Product use in unapproved indicationFAERS: 14US FAERS
82DiscomfortFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
83Failure to ThriveFAERS: 13US FAERS
84Head discomfortFAERS: 13
Canada Vigilance: 3
Canada Vigilance
US FAERS
85InfectionFAERS: 13
Canada Vigilance: 2
2309508
19346865
CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
86TachycardiaFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
87Axonal neuropathyFAERS: 12US FAERS
88DeafnessFAERS: 126584753
7986915
CTD
US FAERS
89Depressed moodFAERS: 12
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
90Dry skinFAERS: 12
Canada Vigilance: 11
Canada Vigilance
OFFSIDES
SIDER
US FAERS
91Impaired driving abilityFAERS: 12US FAERS
92Limb discomfortFAERS: 12US FAERS
93Medication ErrorFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
94Metabolic acidosisFAERS: 12OFFSIDES
US FAERS
95Rash erythematousFAERS: 12
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
96RetchingFAERS: 12US FAERS
97Urinary tract infectionFAERS: 12SIDER
US FAERS
98Vulvovaginal swellingFAERS: 12US FAERS
99BradycardiaFAERS: 11US FAERS
100DehydrationFAERS: 11OFFSIDES
US FAERS
101Documented hypersensitivity to administered productFAERS: 11US FAERS
102FlatulenceFAERS: 11OFFSIDES
SIDER
US FAERS
103Impaired work abilityFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
104Inappropriate schedule of drug administrationFAERS: 11US FAERS
105Status EpilepticusFAERS: 11US FAERS
106Blood glucose increasedFAERS: 10US FAERS
107Clostridium difficile colitisFAERS: 10OFFSIDES
US FAERS
108CryingFAERS: 10OFFSIDES
US FAERS
109Fixed eruptionFAERS: 10US FAERS
110Optic NeuropathyFAERS: 10US FAERS
111Product physical consistency issueFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
112Product solubility abnormalFAERS: 10US FAERS
113Acute psychosisFAERS: 9US FAERS
114Alanine Aminotransferase IncreasedFAERS: 9OFFSIDES
US FAERS
115Deafness NeurosensoryFAERS: 9US FAERS
116Depressed Level of ConsciousnessFAERS: 9US FAERS
117Drug resistanceFAERS: 9US FAERS
118HepatitisFAERS: 9OFFSIDES
SIDER
US FAERS
119InflammationFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
120LeukoencephalopathyFAERS: 9US FAERS
121Nodular rashFAERS: 9US FAERS
122OverdoseFAERS: 9
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
123ParanoiaFAERS: 9US FAERS
124PresyncopeFAERS: 9
Canada Vigilance: 3
Canada Vigilance
US FAERS
125Skin irritationFAERS: 9SIDER
US FAERS
126Altered state of consciousnessFAERS: 8US FAERS
127Disease recurrenceFAERS: 8OFFSIDES
US FAERS
128DysmorphismFAERS: 8US FAERS
129HemiplegiaFAERS: 8US FAERS
130Incorrect route of drug administrationFAERS: 8US FAERS
131Product physical issueFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
132RestlessnessFAERS: 8US FAERS
133SepsisFAERS: 8
Canada Vigilance: 1
552491
9201375
CTD
Canada Vigilance
US FAERS
134Vulvovaginal painFAERS: 8US FAERS
135jaundiceFAERS: 811941968CTD
SIDER
US FAERS
136AcneFAERS: 7
Canada Vigilance: 7
Canada Vigilance
OFFSIDES
US FAERS
137Adverse eventFAERS: 7US FAERS
138AgeusiaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
139AmnesiaFAERS: 7US FAERS
140Angular cheilitisFAERS: 7US FAERS
141AsthmaFAERS: 7SIDER
US FAERS
142Bone painFAERS: 7OFFSIDES
US FAERS
143CandidiasisFAERS: 7US FAERS
144DeliriumFAERS: 7US FAERS
145Drug toxicityFAERS: 7US FAERS
146General physical health deteriorationFAERS: 7US FAERS
147Incorrect drug administration durationFAERS: 7US FAERS
148Mouth swellingFAERS: 7US FAERS
149NeutropeniaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
150Oral pruritusFAERS: 7US FAERS
151Product substitution issueFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
152Serum sickness-like reactionFAERS: 7US FAERS
153Throat irritationFAERS: 7US FAERS
154Vaginal DischargeFAERS: 7SIDER
US FAERS
155Vulvovaginal pruritusFAERS: 7SIDER
US FAERS
156White matter lesionFAERS: 7US FAERS
157Aspartate Aminotransferase IncreasedFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
158BradyphreniaFAERS: 6US FAERS
159DissociationFAERS: 6US FAERS
160Drug dispensing errorFAERS: 6US FAERS
161Drug dose omissionFAERS: 6US FAERS
162Drug effect incompleteFAERS: 6US FAERS
163EpilepsyFAERS: 6OFFSIDES
US FAERS
164Euphoric moodFAERS: 6US FAERS
165HyporeflexiaFAERS: 6US FAERS
166Hypothermia neonatalFAERS: 6US FAERS
167HypoxiaFAERS: 6OFFSIDES
US FAERS
168Infantile ColicFAERS: 6US FAERS
169Mental impairmentFAERS: 6US FAERS
170MyoclonusFAERS: 619452566CTD
US FAERS
171Nerve injuryFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
172NeuropathyFAERS: 6SIDER
US FAERS
173Ocular discomfortFAERS: 6US FAERS
174PharyngitisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
175Slow response to stimuliFAERS: 6US FAERS
176StomatitisFAERS: 6
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
177Unevaluable eventFAERS: 6OFFSIDES
US FAERS
178Vulvovaginal burning sensationFAERS: 6SIDER
US FAERS
179Activities of daily living impairedFAERS: 5US FAERS
180Apparent deathFAERS: 5US FAERS
181Blood alkaline phosphatase increasedFAERS: 5OFFSIDES
US FAERS
182Blood urine presentFAERS: 5OFFSIDES
US FAERS
183ChokingFAERS: 5US FAERS
184Disease ProgressionFAERS: 5US FAERS
185Drug prescribing errorFAERS: 5US FAERS
186DysphoniaFAERS: 5US FAERS
187EosinophiliaFAERS: 5SIDER
US FAERS
188Eye irritationFAERS: 5SIDER
US FAERS
189FormicationFAERS: 5OFFSIDES
US FAERS
190Gamma-Glutamyltransferase IncreasedFAERS: 5OFFSIDES
US FAERS
191Hepatic necrosisFAERS: 5OFFSIDES
US FAERS
192Hypertensive crisisFAERS: 5US FAERS
193Irritable Bowel SyndromeFAERS: 5US FAERS
194LeukopeniaFAERS: 5SIDER
US FAERS
195Lymphomatoid PapulosisFAERS: 5US FAERS
196Maternal exposure during pregnancyFAERS: 5US FAERS
197Memory impairmentFAERS: 5US FAERS
198Muscle tightnessFAERS: 5US FAERS
199Nephrotic SyndromeFAERS: 5OFFSIDES
US FAERS
200NervousnessFAERS: 5
Canada Vigilance: 3
Canada Vigilance
US FAERS
201NeuralgiaFAERS: 5US FAERS
202PolyuriaFAERS: 5SIDER
US FAERS
203Reaction to drug excipientsFAERS: 5US FAERS
204Toxic Optic NeuropathyFAERS: 5US FAERS
205Urinary RetentionFAERS: 5US FAERS
206Wrong technique in drug usage processFAERS: 5US FAERS
207Abdominal tendernessFAERS: 4US FAERS
208Accidental exposure to productFAERS: 4US FAERS
209Application site painFAERS: 4US FAERS
210Atrial FibrillationFAERS: 4US FAERS
211Autonomic neuropathyFAERS: 4US FAERS
212Blood creatinine increasedFAERS: 4US FAERS
213Blood glucose decreasedFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
214ChloasmaFAERS: 4US FAERS
215Drug administration errorFAERS: 4US FAERS
216Ear discomfortFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
217EpistaxisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
218Facial paralysisFAERS: 4US FAERS
219GastritisFAERS: 4US FAERS
220Gastrointestinal PainFAERS: 4SIDER
US FAERS
221Gaze palsyFAERS: 4US FAERS
222Genitourinary tract gonococcal infectionFAERS: 4US FAERS
223GlossitisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
224Guillain-Barre SyndromeFAERS: 4US FAERS
225HypogeusiaFAERS: 4US FAERS
226Incorrect dose administeredFAERS: 4
Canada Vigilance: 10
Canada Vigilance
US FAERS
227Intentional product use issueFAERS: 4US FAERS
228KeratitisFAERS: 4US FAERS
229Lipase increasedFAERS: 4US FAERS
230LymphadenopathyFAERS: 4US FAERS
231Night sweatsFAERS: 4US FAERS
232Noninfective gingivitisFAERS: 4US FAERS
233Oral candidiasisFAERS: 4US FAERS
234Oromandibular dystoniaFAERS: 4US FAERS
235Oropharyngeal plaqueFAERS: 4US FAERS
236OtotoxicityFAERS: 4US FAERS
237Pain of skinFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
238Patent ductus arteriosusFAERS: 4US FAERS
239Pharyngolaryngeal PainFAERS: 4OFFSIDES
US FAERS
240Posterior reversible encephalopathy syndromeFAERS: 4US FAERS
241Renal painFAERS: 4US FAERS
242Romberg test positiveFAERS: 4US FAERS
243Septic ShockFAERS: 4OFFSIDES
US FAERS
244Serum SicknessFAERS: 4SIDER
US FAERS
245Skin lesionFAERS: 4US FAERS
246Skin texture abnormalFAERS: 4US FAERS
247SynostosisFAERS: 4US FAERS
248Therapeutic response unexpectedFAERS: 4US FAERS
249ThrombocytopeniaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
250Tongue blisteringFAERS: 4US FAERS
251prostatitisFAERS: 4US FAERS
252Acute kidney injuryFAERS: 3US FAERS
253AllodyniaFAERS: 3US FAERS
254AnorexiaFAERS: 317061489CTD
OFFSIDES
SIDER
US FAERS
255AnuriaFAERS: 3US FAERS
256Apallic syndromeFAERS: 3US FAERS
257Application site erythemaFAERS: 3US FAERS
258ArthritisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
259Cardiac ArrestFAERS: 3US FAERS
260CataractFAERS: 3OFFSIDES
US FAERS
261Cerebral disorderFAERS: 3US FAERS
262ClumsinessFAERS: 3US FAERS
263Consciousness fluctuatingFAERS: 3US FAERS
264CyanosisFAERS: 3OFFSIDES
US FAERS
265DermatitisFAERS: 3SIDER
US FAERS
266Embolic strokeFAERS: 3US FAERS
267Emotional distressFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
268Exposure via breast milkFAERS: 3US FAERS
269Flat affectFAERS: 3US FAERS
270Food AllergyFAERS: 3US FAERS
271GastroenteritisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
272Gingival erythemaFAERS: 3OFFSIDES
US FAERS
273Gluten sensitivityFAERS: 3US FAERS
274Hepatic EncephalopathyFAERS: 315765436
15778547
19452566
CTD
US FAERS
275HypersomniaFAERS: 3US FAERS
276HyperventilationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
277HypokinesiaFAERS: 3US FAERS
278HypophagiaFAERS: 3OFFSIDES
US FAERS
279Inappropriate affectFAERS: 3US FAERS
280Lymphatic system neoplasmFAERS: 3US FAERS
281Mood swingsFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
282Musculoskeletal PainFAERS: 3US FAERS
283Myocardial InfarctionFAERS: 3US FAERS
284Optic AtrophyFAERS: 3US FAERS
285Oral mucosal erythemaFAERS: 3US FAERS
286Oral painFAERS: 3US FAERS
287PapuleFAERS: 3US FAERS
288Pharmaceutical product complaintFAERS: 3US FAERS
289Product contaminationFAERS: 3US FAERS
290Product label issueFAERS: 3US FAERS
291PurulenceFAERS: 3US FAERS
292Pustular psoriasisFAERS: 3US FAERS
293Restless Legs SyndromeFAERS: 3US FAERS
294Stevens-Johnson SyndromeFAERS: 325811541CTD
OFFSIDES
SIDER
US FAERS
295Subcutaneous AbscessFAERS: 3
Canada Vigilance: 3
Canada Vigilance
US FAERS
296Therapy cessationFAERS: 3US FAERS
297Unresponsive to stimuliFAERS: 3US FAERS
298Urethritis noninfectiveFAERS: 3US FAERS
299Urine alcohol test positiveFAERS: 3US FAERS
300VasculitisFAERS: 3US FAERS
301Vitreous floatersFAERS: 3US FAERS
302pseudomembranous colitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
303Accidental overdoseFAERS: 2US FAERS
304Acute myocardial infarctionFAERS: 2US FAERS
305AgnosiaFAERS: 2US FAERS
306Alcohol IntoleranceFAERS: 2US FAERS
307Alcohol interactionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
308Alcohol poisoningFAERS: 2US FAERS
309Anorectal discomfortFAERS: 2US FAERS
310AphagiaFAERS: 2US FAERS
311Application site dischargeFAERS: 2US FAERS
312Application site pruritusFAERS: 2US FAERS
313Application site rashFAERS: 2US FAERS
314ArthropathyFAERS: 2OFFSIDES
US FAERS
315AsthenopiaFAERS: 2US FAERS
316BedriddenFAERS: 2US FAERS
317Bladder discomfortFAERS: 2US FAERS
318Blood bilirubin abnormalFAERS: 2US FAERS
319Blood creatine phosphokinase increasedFAERS: 2US FAERS
320Blood glucose fluctuationFAERS: 2US FAERS
321Blood pressure fluctuationFAERS: 2OFFSIDES
US FAERS
322CatatoniaFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
323CheilitisFAERS: 2US FAERS
324ChoreaFAERS: 219452566CTD
US FAERS
325Clostridium colitisFAERS: 2OFFSIDES
US FAERS
326Clostridium test positiveFAERS: 2US FAERS
327Cogwheel RigidityFAERS: 2US FAERS
328Cold sweatFAERS: 2US FAERS
329Coma scale abnormalFAERS: 2US FAERS
330Conversion disorderFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
331CraniosynostosisFAERS: 2US FAERS
332Cutaneous T-cell dyscrasiaFAERS: 2US FAERS
333Decreased vibratory senseFAERS: 2US FAERS
334DemyelinationFAERS: 2OFFSIDES
US FAERS
335DiverticulitisFAERS: 219101108CTD
OFFSIDES
US FAERS
336Documented hypersensitivity to administered drugFAERS: 2US FAERS
337DysbacteriosisFAERS: 2US FAERS
338DystoniaFAERS: 23371193CTD
US FAERS
339Electroencephalogram abnormalFAERS: 2US FAERS
340Extra dose administeredFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
341Extraocular Muscle ParesisFAERS: 2US FAERS
342Feeling ColdFAERS: 2US FAERS
343Feeling jitteryFAERS: 2US FAERS
344Feeling of body temperature changeFAERS: 2US FAERS
345Flank PainFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
346Foreign body sensation in eyesFAERS: 2US FAERS
347Gastric pH decreasedFAERS: 2US FAERS
348Genital burning sensationFAERS: 2US FAERS
349HepatotoxicityFAERS: 2US FAERS
350HungerFAERS: 2US FAERS
351HyperreflexiaFAERS: 2US FAERS
352Hypoaesthesia facialFAERS: 2US FAERS
353Hypotonic-hyporesponsive episodeFAERS: 2US FAERS
354IncontinenceFAERS: 2OFFSIDES
SIDER
US FAERS
355InfluenzaFAERS: 2SIDER
US FAERS
356Intentional product misuseFAERS: 2
Canada Vigilance: 3
Canada Vigilance
US FAERS
357Joint stiffnessFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
358Kounis SyndromeFAERS: 2US FAERS
359Large intestine perforationFAERS: 2US FAERS
360Liver AbscessFAERS: 23725639CTD
OFFSIDES
US FAERS
361Long QT SyndromeFAERS: 215869686CTD
US FAERS
362Loss of personal independence in daily activitiesFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
363LymphomaFAERS: 2OFFSIDES
US FAERS
364MeningitisFAERS: 26492947CTD
US FAERS
365MetrorrhagiaFAERS: 2SIDER
US FAERS
366Middle insomniaFAERS: 2US FAERS
367Muscle enzyme increasedFAERS: 2US FAERS
368MyocarditisFAERS: 2US FAERS
369NecrosisFAERS: 2US FAERS
370NeuritisFAERS: 22934717
7316307
19217129
CTD
SIDER
US FAERS
371Nuclear magnetic resonance imaging brain normalFAERS: 2US FAERS
372OligohydramniosFAERS: 2US FAERS
373Optic NeuritisFAERS: 2US FAERS
374Oral fungal infectionFAERS: 2OFFSIDES
US FAERS
375Oropharyngeal swellingFAERS: 2US FAERS
376Panic DisorderFAERS: 23992315CTD
US FAERS
377Pathogen resistanceFAERS: 2US FAERS
378Pelvic PainFAERS: 2US FAERS
379Peripheral motor neuropathyFAERS: 2US FAERS
380Personality ChangeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
381PneumoniaFAERS: 2US FAERS
382PregnancyFAERS: 2SIDER
US FAERS
383Prescribed overdoseFAERS: 2US FAERS
384Product contamination physicalFAERS: 2US FAERS
385Product difficult to swallowFAERS: 2US FAERS
386Product formulation issueFAERS: 2US FAERS
387Product outer packaging issueFAERS: 2US FAERS
388Product packaging issueFAERS: 2US FAERS
389Product packaging quantity issueFAERS: 2US FAERS
390Product use complaintFAERS: 2US FAERS
391Productive CoughFAERS: 2US FAERS
392Pulmonary EmbolismFAERS: 2US FAERS
393Respiratory arrestFAERS: 2US FAERS
394Respiratory distressFAERS: 2US FAERS
395Secretion dischargeFAERS: 2US FAERS
396Similar reaction on previous exposure to drugFAERS: 2US FAERS
397Sinus headacheFAERS: 2US FAERS
398Skin UlcerFAERS: 2US FAERS
399Skin discomfortFAERS: 2SIDER
US FAERS
400Skin tightnessFAERS: 2OFFSIDES
SIDER
US FAERS
401Slow speechFAERS: 2US FAERS
402SneezingFAERS: 2US FAERS
403StillbirthFAERS: 2US FAERS
404SunburnFAERS: 2US FAERS
405Temporal ArteritisFAERS: 2US FAERS
406Therapy non-responderFAERS: 2US FAERS
407ToothacheFAERS: 2US FAERS
408Toxic Epidermal NecrolysisFAERS: 2SIDER
US FAERS
409Transmission of drug via semenFAERS: 2US FAERS
410Troponin I increasedFAERS: 2US FAERS
411Type III immune complex mediated reactionFAERS: 2US FAERS
412Ventricular FibrillationFAERS: 2OFFSIDES
US FAERS
413Visual disturbanceFAERS: 2US FAERS
414Vitreous DetachmentFAERS: 2US FAERS
415Vulvovaginal erythemaFAERS: 2US FAERS
416Vulvovaginal mycotic infectionFAERS: 2SIDER
US FAERS
417Wernicke-Korsakoff SyndromeFAERS: 2US FAERS
418Wrong technique in product usage processFAERS: 2US FAERS
419Accidental exposureFAERS: 1US FAERS
420Administration site dischargeFAERS: 1US FAERS
421Administration site pruritusFAERS: 1US FAERS
422Administration site urticariaFAERS: 1US FAERS
423AgranulocytosisFAERS: 1SIDER
US FAERS
424Allergic reaction to excipientFAERS: 1US FAERS
425AlopeciaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
426Amylase increasedFAERS: 1US FAERS
427Anal FissureFAERS: 1US FAERS
428Anaphylactoid ReactionFAERS: 1US FAERS
429Anaphylaxis prophylaxisFAERS: 1US FAERS
430AngerFAERS: 1US FAERS
431Angina PectorisFAERS: 1US FAERS
432Antinuclear antibody increasedFAERS: 1US FAERS
433ApathyFAERS: 1OFFSIDES
US FAERS
434Application site alopeciaFAERS: 1US FAERS
435Application site burnFAERS: 1US FAERS
436Application site drynessFAERS: 1US FAERS
437Application site inflammationFAERS: 1US FAERS
438Application site irritationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
439Application site swellingFAERS: 1US FAERS
440Application site vesiclesFAERS: 1US FAERS
441AtelectasisFAERS: 1OFFSIDES
US FAERS
442Atrial FlutterFAERS: 1OFFSIDES
US FAERS
443Auricular swellingFAERS: 1US FAERS
444Autoimmune hepatitisFAERS: 1US FAERS
445Autonomic nervous system imbalanceFAERS: 1US FAERS
446Back disorderFAERS: 1OFFSIDES
US FAERS
447Bacterial VaginosisFAERS: 1US FAERS
448Biliary sepsisFAERS: 1US FAERS
449Biopsy liver abnormalFAERS: 1US FAERS
450Blood amylase increasedFAERS: 1US FAERS
451Blood phosphorus increasedFAERS: 1US FAERS
452Blood potassium increasedFAERS: 1US FAERS
453Blood sodium decreasedFAERS: 1US FAERS
454Bowel movement irregularityFAERS: 1US FAERS
455Brain AbscessFAERS: 119118962CTD
US FAERS
456Brain stem syndromeFAERS: 1US FAERS
457Breast tendernessFAERS: 1US FAERS
458Breech PresentationFAERS: 1US FAERS
459Buccal mucosal rougheningFAERS: 1US FAERS
460CD30 expressionFAERS: 1US FAERS
461CalcinosisFAERS: 1US FAERS
462Cardiac FlutterFAERS: 1OFFSIDES
US FAERS
463Cardiovascular insufficiencyFAERS: 1US FAERS
464Cerebral ataxiaFAERS: 1US FAERS
465Cerebral atrophyFAERS: 1OFFSIDES
US FAERS
466Chemical burn of skinFAERS: 1US FAERS
467Choking sensationFAERS: 1OFFSIDES
US FAERS
468CholestasisFAERS: 111941968CTD
US FAERS
469Citrobacter infectionFAERS: 1US FAERS
470Coital bleedingFAERS: 1US FAERS
471ColectomyFAERS: 1OFFSIDES
US FAERS
472ColitisFAERS: 12306432
8071518
17224569
CTD
OFFSIDES
US FAERS
473Congenital brain damageFAERS: 1US FAERS
474CystitisFAERS: 1SIDER
US FAERS
475CytopeniaFAERS: 1US FAERS
476Dacryostenosis acquiredFAERS: 1US FAERS
477DementiaFAERS: 1US FAERS
478Dental cariesFAERS: 1OFFSIDES
US FAERS
479Device FailureFAERS: 1US FAERS
480Device related infectionFAERS: 1US FAERS
481Diet refusalFAERS: 1US FAERS
482Disseminated Intravascular CoagulationFAERS: 1US FAERS
483Drug ToleranceFAERS: 1US FAERS
484Drug effect delayedFAERS: 1US FAERS
485Drug effect variableFAERS: 1US FAERS
486Drug screen false positiveFAERS: 1US FAERS
487Drug screen positiveFAERS: 1US FAERS
488DyscheziaFAERS: 1US FAERS
489DysenteryFAERS: 1US FAERS
490DysgraphiaFAERS: 1US FAERS
491EcchymosisFAERS: 1US FAERS
492EczemaFAERS: 1US FAERS
493Electrolyte imbalanceFAERS: 1US FAERS
494Electromechanical dissociationFAERS: 1OFFSIDES
US FAERS
495Emotional disorderFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
496EncephalitisFAERS: 1US FAERS
497EnuresisFAERS: 1US FAERS
498Epidermal necrosisFAERS: 1US FAERS
499Epstein-Barr virus test positiveFAERS: 1US FAERS
500Erectile dysfunctionFAERS: 1OFFSIDES
US FAERS
501Expired drug administeredFAERS: 1US FAERS
502Exposure to toxic agentFAERS: 1US FAERS
503Exposure via eye contactFAERS: 1US FAERS
504ExtravasationFAERS: 1US FAERS
505Eye InfectionFAERS: 1US FAERS
506Eyelid Function DisorderFAERS: 1US FAERS
507Eyelid margin crustingFAERS: 1US FAERS
508Facial PainFAERS: 1US FAERS
509Foreign body in respiratory tractFAERS: 1US FAERS
510FractureFAERS: 1US FAERS
511Frustration tolerance decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
512Gastric DilatationFAERS: 1US FAERS
513Gastrointestinal candidiasisFAERS: 1US FAERS
514Gastrointestinal hypermotilityFAERS: 1US FAERS
515Gastrointestinal inflammationFAERS: 1US FAERS
516Gastrointestinal perforationFAERS: 1US FAERS
517Gastrointestinal sounds abnormalFAERS: 1US FAERS
518Gastrointestinal ulcerFAERS: 1US FAERS
519General physical condition abnormalFAERS: 1US FAERS
520Genito-pelvic pain/penetration disorderFAERS: 1US FAERS
521Gestational DiabetesFAERS: 1US FAERS
522Gingival blisterFAERS: 1US FAERS
523Grip strength decreasedFAERS: 1US FAERS
524HepatomegalyFAERS: 1US FAERS
525HydrocephalusFAERS: 116316810CTD
OFFSIDES
US FAERS
526HyperacusisFAERS: 1US FAERS
527HypercapniaFAERS: 1US FAERS
528HyperpyrexiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
529HypertrophyFAERS: 1US FAERS
530HypometabolismFAERS: 1US FAERS
531IleitisFAERS: 1US FAERS
532Immunoglobulins abnormalFAERS: 1US FAERS
533Inappropriate schedule of product administrationFAERS: 1
Canada Vigilance: 11
Canada Vigilance
US FAERS
534IncoherentFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
535Incorrect product administration durationFAERS: 1
Canada Vigilance: 8
Canada Vigilance
US FAERS
536Incorrect route of product administrationFAERS: 1US FAERS
537Increased upper airway secretionFAERS: 1US FAERS
538Infection reactivationFAERS: 1US FAERS
539Infusion Site ExtravasationFAERS: 1US FAERS
540Initial insomniaFAERS: 1US FAERS
541Injection site extravasationFAERS: 1US FAERS
542Intention tremorFAERS: 1US FAERS
543Intercepted product prescribing errorFAERS: 1US FAERS
544Intestinal ObstructionFAERS: 1OFFSIDES
US FAERS
545Intrusive thoughtsFAERS: 1US FAERS
546Irregular sleep wake rhythm disorderFAERS: 1US FAERS
547Joint Range of Motion DecreasedFAERS: 1US FAERS
548Joint injuryFAERS: 1US FAERS
549Juvenile arthritisFAERS: 1US FAERS
550Labile blood pressureFAERS: 1US FAERS
551Laryngeal discomfortFAERS: 1US FAERS
552Leukocytoclastic vasculitisFAERS: 1US FAERS
553Lid sulcus deepenedFAERS: 1US FAERS
554Lip exfoliationFAERS: 1US FAERS
555Lymphocyte percentage decreasedFAERS: 1US FAERS
556Lymphocyte percentage increasedFAERS: 1US FAERS
557LymphocytosisFAERS: 1US FAERS
558MalabsorptionFAERS: 1US FAERS
559Maternal exposure timing unspecifiedFAERS: 1US FAERS
560Medical device complicationFAERS: 1US FAERS
561Medication residueFAERS: 1US FAERS
562MegacolonFAERS: 1US FAERS
563MeningismFAERS: 1US FAERS
564MenorrhagiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
565Migraine with AuraFAERS: 1US FAERS
566Mitochondrial toxicityFAERS: 1US FAERS
567MonoparesisFAERS: 1US FAERS
568MonoplegiaFAERS: 1US FAERS
569Mouth cystFAERS: 1US FAERS
570Mucosal excoriationFAERS: 1US FAERS
571Mucosal necrosisFAERS: 1US FAERS
572Multiple drug overdoseFAERS: 1US FAERS
573Muscle RigidityFAERS: 1US FAERS
574Musculoskeletal chest painFAERS: 1OFFSIDES
US FAERS
575Musculoskeletal discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
576Myasthenia GravisFAERS: 1US FAERS
577MyopiaFAERS: 1SIDER
US FAERS
578Nasal discomfortFAERS: 1US FAERS
579Neonatal respiratory distressFAERS: 1US FAERS
580NephrolithiasisFAERS: 1OFFSIDES
US FAERS
581Neurological examination abnormalFAERS: 1US FAERS
582Neutrophil count decreasedFAERS: 1US FAERS
583No reaction on previous exposure to drugFAERS: 1US FAERS
584OliguriaFAERS: 1OFFSIDES
US FAERS
585Open woundFAERS: 1US FAERS
586Ophthalmic vein thrombosisFAERS: 1US FAERS
587Oral allergy syndromeFAERS: 1US FAERS
588Oropharyngeal blisteringFAERS: 1US FAERS
589Oropharyngeal discomfortFAERS: 1US FAERS
590OsteoporosisFAERS: 1OFFSIDES
US FAERS
591Palatal swellingFAERS: 1US FAERS
592PallorFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
593Pancreatic carcinomaFAERS: 1US FAERS
594PancytopeniaFAERS: 1SIDER
US FAERS
595ParaparesisFAERS: 1US FAERS
596Patient uncooperativeFAERS: 1US FAERS
597Penile size reducedFAERS: 1US FAERS
598Periorbital disorderFAERS: 1US FAERS
599PhlebitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
600PneumoperitoneumFAERS: 1OFFSIDES
US FAERS
601PoisoningFAERS: 1US FAERS
602Poor peripheral circulationFAERS: 1US FAERS
603Poor quality drug administeredFAERS: 1US FAERS
604Poor quality product administeredFAERS: 1US FAERS
605Post procedural complicationFAERS: 1US FAERS
606Post procedural infectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
607PouchitisFAERS: 1US FAERS
608Precancerous skin lesionFAERS: 1US FAERS
609Prescribed underdoseFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
610Pressure of speechFAERS: 1US FAERS
611Product container issueFAERS: 1US FAERS
612Product contamination microbialFAERS: 1US FAERS
613Product dispensing errorFAERS: 1US FAERS
614Product dose omissionFAERS: 1US FAERS
615Product friableFAERS: 1US FAERS
616Product label confusionFAERS: 1US FAERS
617Product prescribing errorFAERS: 1US FAERS
618Product residue presentFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
619Product size issueFAERS: 1US FAERS
620Prostatic painFAERS: 1US FAERS
621Protein urine presentFAERS: 1US FAERS
622ProteinuriaFAERS: 1US FAERS
623Psychomotor AgitationFAERS: 15789554
7167392
11229167
CTD
US FAERS
624Pulmonary HypertensionFAERS: 1US FAERS
625Pulmonary congestionFAERS: 1US FAERS
626PurpuraFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
627PyuriaFAERS: 1SIDER
US FAERS
628RadiculitisFAERS: 1US FAERS
629Reaction to excipientFAERS: 1US FAERS
630Rebound effectFAERS: 1US FAERS
631Recall phenomenonFAERS: 1US FAERS
632Renal cystFAERS: 1OFFSIDES
US FAERS
633Respiratory DepressionFAERS: 1US FAERS
634Respiratory FailureFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
635Reticulocyte count increasedFAERS: 1US FAERS
636SarcoidosisFAERS: 1US FAERS
637ScabFAERS: 1US FAERS
638SciaticaFAERS: 1US FAERS
639Seizure like phenomenaFAERS: 1US FAERS
640Serotonin SyndromeFAERS: 1US FAERS
641Sexual DysfunctionFAERS: 1US FAERS
642SinusitisFAERS: 1OFFSIDES
SIDER
US FAERS
643Sjogren's SyndromeFAERS: 1US FAERS
644Skin hypertrophyFAERS: 1
Canada Vigilance: 6
Canada Vigilance
US FAERS
645Skin necrosisFAERS: 1US FAERS
646Skin reactionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
647Skin test positiveFAERS: 1US FAERS
648Spinal column injuryFAERS: 1US FAERS
649Streptococcus test positiveFAERS: 1US FAERS
650Suicide attemptFAERS: 1US FAERS
651Supraventricular tachycardiaFAERS: 1US FAERS
652Suspected product contaminationFAERS: 1US FAERS
653Suspected transmission of an infectious agent via productFAERS: 1US FAERS
654Swelling of eyelidFAERS: 1US FAERS
655Tablet issueFAERS: 1US FAERS
656TachyphreniaFAERS: 1US FAERS
657Tension HeadacheFAERS: 1US FAERS
658TensionFAERS: 1US FAERS
659Thought insertionFAERS: 1US FAERS
660Thrombocytopenic purpuraFAERS: 1US FAERS
661Tinea PedisFAERS: 1US FAERS
662Tongue fungal infectionFAERS: 1US FAERS
663Toxic Shock SyndromeFAERS: 1US FAERS
664TrismusFAERS: 1US FAERS
665Tryptase increasedFAERS: 1US FAERS
666UlcerFAERS: 19421124CTD
OFFSIDES
US FAERS
667Upper motor neurone lesionFAERS: 1US FAERS
668Upper-airway cough syndromeFAERS: 1US FAERS
669Urinary IncontinenceFAERS: 1US FAERS
670Uterine PolypFAERS: 1US FAERS
671Uterine inflammationFAERS: 1US FAERS
672VIIth nerve paralysisFAERS: 1US FAERS
673Vaginal mucosal blisteringFAERS: 1US FAERS
674Vaginal painFAERS: 1US FAERS
675Vascular purpuraFAERS: 1US FAERS
676Ventricular arrhythmiaFAERS: 1US FAERS
677Vulvovaginal discomfortFAERS: 1US FAERS
678Walking aid userFAERS: 1US FAERS
679WheezingFAERS: 1US FAERS
680White blood cell count decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
681Wrong doseFAERS: 1US FAERS
682Wrong drug administeredFAERS: 1US FAERS
683furuncleFAERS: 1US FAERS
684muscle injuryFAERS: 1OFFSIDES
US FAERS
685Abdominal AbscessCanada Vigilance: 111778010
13679281
19752101
CTD
Canada Vigilance
686Abdominal CrampsSIDER
687Abdominal adhesionsOFFSIDES
688Abdominal bloatingSIDER
689Abdominal distressSIDER
690Abdominal sepsisOFFSIDES
691Abnormalities, Drug-Induced16316810CTD
692Abscess7316307
18319500
CTD
OFFSIDES
693AcidosisOFFSIDES
694Acneiform Eruptions21738965CTD
695Acute respiratory failureOFFSIDES
696AdenomaOFFSIDES
697AgraphiaOFFSIDES
698AkathisiaCanada Vigilance: 1Canada Vigilance
699AkinesiaCanada Vigilance: 1Canada Vigilance
700AlkalosisOFFSIDES
701AmblyopiaOFFSIDES
702Amebiasis7123
11528241
CTD
703Anal candidiasisOFFSIDES
704Anemia15125692CTD
705AnhedoniaOFFSIDES
706Aortic valve sclerosisOFFSIDES
707Application site reactionSIDER
708Arterial thrombosisOFFSIDES
709ArthroscopyOFFSIDES
710AscitesOFFSIDES
711Atrial tachycardiaOFFSIDES
712Atrioventricular BlockOFFSIDES
713BK virus infectionOFFSIDES
714Bacteremia11098341CTD
715Bacterial Infections11528241CTD
716Bacterial test positiveOFFSIDES
717Bacteroides Infections11098341CTD
718BalanitisOFFSIDES
719Basal cell carcinomaSIDER
720Biliary adenomaOFFSIDES
721Bipolar Disorder11799346CTD
OFFSIDES
722Bladder painSIDER
723Blood GlucoseOFFSIDES
724Blood and lymphatic system disordersSIDER
725Blood cholesterolOFFSIDES
726Blood potassium decreasedOFFSIDES
727Bone density decreasedOFFSIDES
728Bone marrow depressionSIDER
729Bone swellingOFFSIDES
730BradykinesiaCanada Vigilance: 1Canada Vigilance
731Brain Diseases

View details

CTD
732Brain Edema13679281
17224569
CTD
733Brain scan abnormalOFFSIDES
734Bronchiectasis19752101CTD
735BronchitisSIDER
736BronchospasmCanada Vigilance: 1Canada Vigilance
737Burning feeling vaginaSIDER
738BursitisOFFSIDES
739Calcific deposits removalOFFSIDES
740Candida cervicitisSIDER
741Cat Diseases16145214CTD
742Catheter sepsisOFFSIDES
743Cellulitis11528241CTD
OFFSIDES
744Cerebellar Diseases

View details

CTD
745Cerebral Hemorrhage18396247CTD
746Chemical and Drug Induced Liver Injury11941968CTD
747CholangiolitisOFFSIDES
748Chronic Obstructive Airway DiseaseOFFSIDES
749Chronic left ventricular failureOFFSIDES
750Chronic sinusitisOFFSIDES
751Clostridium Infections15855244
17224569
17604593
CTD
752ClubbingOFFSIDES
753Cognition Disorders842719CTD
754Colon adenomaOFFSIDES
755Colon cancer recurrentOFFSIDES
756Colonic Neoplasms1358165CTD
757Color vision changeSIDER
758Compression fractureOFFSIDES
759ConfabulationOFFSIDES
760Confusion

View details

CTD
761Congenital heart valve disorderOFFSIDES
762Congenital tricuspid valve incompetenceOFFSIDES
763ConjunctivitisCanada Vigilance: 1Canada Vigilance
SIDER
764Crohn Disease

View details

CTD
765DebridementOFFSIDES
766Deglutition Disorders14676060
15960179
CTD
767Dental FistulaOFFSIDES
768Depressive disorder842719
5789554
CTD
769DiabetesOFFSIDES
770Diabetes mellitus inadequate controlOFFSIDES
771Diabetic ulcerOFFSIDES
772Diarrhea9398876
17604593
CTD
OFFSIDES
773Disorders of Excessive Somnolence20171413CTD
774DistressSIDER
775Disturbance in sexual arousalSIDER
776DiverticulosisOFFSIDES
777DrowsinessSIDER
778Drug Eruptions11792017CTD
779Drug addictOFFSIDES
780Duodenal Ulcer17316343CTD
781DyspareuniaSIDER
782Dysthymic DisorderOFFSIDES
783Economic problemOFFSIDES
784Electrocardiogram abnormalCanada Vigilance: 1Canada Vigilance
785EndocarditisOFFSIDES
786Endodontic procedureOFFSIDES
787Entamoebiasis7986915CTD
788Enterococcal infectionOFFSIDES
789Enterocolitis, Pseudomembranous10830559
12642754
15869686
CTD
790EpicondylitisOFFSIDES
791Epidural Abscess11778010CTD
792Epigastric distressSIDER
793Epigastric painSIDER
794EructationSIDER
795Erythema MultiformeSIDER
796Escherichia coli Infections3165976CTD
797Eustachian tube disorderOFFSIDES
798Extremity contractureOFFSIDES
799Extremity necrosisOFFSIDES
800Eye symptomCanada Vigilance: 3Canada Vigilance
801Febrile NeutropeniaOFFSIDES
802Feeding and Eating Disorders842719
17333792
CTD
803Feeding tube complicationOFFSIDES
804Female Urogenital Diseases842719CTD
805Fibroadenoma of breastOFFSIDES
806Fistula dischargeOFFSIDES
807Gait Ataxia15778547
19452566
19560788
CTD
808Gait Disorders, Neurologic

View details

CTD
809GamblingOFFSIDES
810Gastrointestinal Diseases6336861
14731313
CTD
811Gastrointestinal discomfortSIDER
812Genital rashCanada Vigilance: 1Canada Vigilance
813Giardiasis17333792
17385912
20946968
CTD
814GingivitisSIDER
815Gram stain positiveOFFSIDES
816Gram-Negative Bacterial Infections17061489CTD
817Granulocyte count decreasedCanada Vigilance: 1Canada Vigilance
818Hallucinations4603136
7167392
12642754
CTD
819Helicobacter Infections

View details

CTD
820Hemolytic-Uremic Syndrome2306432
3173180
CTD
821Heparin-induced thrombocytopeniaOFFSIDES
822High frequency ablationOFFSIDES
823Hyperalgesia198056CTD
824HyperkeratosisOFFSIDES
825HyperpigmentationOFFSIDES
826Hypesthesia912357CTD
827Immune reconstitution syndromeOFFSIDES
828Impaired quality of lifeCanada Vigilance: 1Canada Vigilance
829ImpetigoOFFSIDES
830Increased tendency to bruiseCanada Vigilance: 1Canada Vigilance
831InfestationSIDER
832Inflammatory Bowel Diseases1358165
16145214
CTD
833Influenza-like symptomsSIDER
834Infusion site mobility decreasedOFFSIDES
835Injection Site ReactionCanada Vigilance: 1Canada Vigilance
836Intestinal PerforationOFFSIDES
837Kidney FailureOFFSIDES
838Lactation DisorderCanada Vigilance: 1Canada Vigilance
839LaparotomyOFFSIDES
840LaryngospasmCanada Vigilance: 1Canada Vigilance
OFFSIDES
841Left atrial dilatationOFFSIDES
842Leukemia L12102156514CTD
843Leukopenia neonatalOFFSIDES
844LeukorrheaSIDER
845Leydig Cell Tumor288941CTD
846Ligament ruptureOFFSIDES
847Lip erosionOFFSIDES
848Livedo ReticularisOFFSIDES
849Liver Abscess, Amebic

View details

CTD
850Liver Failure, Acute11941968CTD
851Liver Neoplasms, Experimental288941CTD
852Liver transplant rejectionOFFSIDES
853Local reactionSIDER
854Lupus-like syndromeOFFSIDES
855Malignant neoplasm progressionOFFSIDES
856MalnutritionCanada Vigilance: 1Canada Vigilance
857Mammary Neoplasms, Experimental288941CTD
858Mass excisionOFFSIDES
859Meningitis, Bacterial11098341CTD
860Meniscus removalOFFSIDES
861MicrographiaCanada Vigilance: 1Canada Vigilance
862Mitral valve sclerosisOFFSIDES
863Monoclonal immunoglobulin presentOFFSIDES
864Motor retardationOFFSIDES
865Mouth Diseases10474673CTD
866Movement Disorders3025992
19452566
CTD
867Multiple sclerosis relapseOFFSIDES
868Muscle WeaknessOFFSIDES
869Muscle necrosisOFFSIDES
870MyelitisCanada Vigilance: 1Canada Vigilance
OFFSIDES
871NasopharyngitisSIDER
872Neonatal aspirationOFFSIDES
873Nephrogenic Fibrosing DermopathyOFFSIDES
874Neurotoxicity Syndromes15765436CTD
875Non-cardiac chest painOFFSIDES
876Numbness of limbsSIDER
877NumbnessSIDER
878Occult blood positiveOFFSIDES
879Oedema labial genitalSIDER
880OnychalgiaOFFSIDES
881OsteochondrosisOFFSIDES
882OsteolysisOFFSIDES
883Osteomyelitis18511323
20171413
CTD
OFFSIDES
884OsteopeniaOFFSIDES
885OsteosclerosisOFFSIDES
886Paresis16145214CTD
887Paresthesia of limbsSIDER
888Paresthesia

View details

CTD
889Partner stressOFFSIDES
890Pelvic Inflammatory Disease9247414CTD
891Pelvic discomfortSIDER
892Peptic Ulcer9570262CTD
893Pericardial effusionOFFSIDES
894Periodontitis20011938CTD
895Peripheral Nervous System Diseases

View details

CTD
896Peritoneal lavageOFFSIDES
897Peritonitis15765436CTD
898Physical abuseOFFSIDES
899Pituitary Neoplasms288941CTD
900PneumothoraxOFFSIDES
901PolymenorrheaOFFSIDES
902Polymyalgia RheumaticaOFFSIDES
903Poor quality sleepOFFSIDES
904Positron emission tomogram abnormalOFFSIDES
905Pregnancy on contraceptiveOFFSIDES
906Primary sequestrumOFFSIDES
907Procedural site reactionOFFSIDES
908ProctitisCanada Vigilance: 1Canada Vigilance
SIDER
909Protozoan Infections15778547CTD
910Psychoses, Substance-Induced9247414
19357607
CTD
911Pulmonary Valve StenosisOFFSIDES
912Purulent dischargeCanada Vigilance: 1Canada Vigilance
OFFSIDES
913PyomyositisOFFSIDES
914Radicular painOFFSIDES
915Rectal polypOFFSIDES
916RednessSIDER
917Reflex, Abnormal15960179CTD
918Reflux gastritisOFFSIDES
919Reflux laryngitisOFFSIDES
920Renal Insufficiency2306432CTD
921RhabdomyolysisOFFSIDES
922RhinitisOFFSIDES
SIDER
923RhonchiOFFSIDES
924Risus sardonicusOFFSIDES
925SalpingitisSIDER
926Salpingo-oophorectomyOFFSIDES
927Sarcoma, Experimental7150475CTD
928SchizophreniaOFFSIDES
929SclerodermaOFFSIDES
930ScotomaOFFSIDES
931ScreamingOFFSIDES
932Seizures

View details

CTD
933SequestrectomyOFFSIDES
934Shoulder PainOFFSIDES
935Sleep Initiation and Maintenance Disorders5789554CTD
936Speech Disorders11098341CTD
937Spinal claudicationOFFSIDES
938SplenectomyOFFSIDES
939Splenic InfarctionOFFSIDES
940Splenic InfectionOFFSIDES
941Splenic abscessOFFSIDES
942Splenic necrosisOFFSIDES
943SpondylolysisOFFSIDES
944Sputum culture positiveOFFSIDES
945Staphylococcal Infections7645562CTD
946Stenotrophomonas infectionOFFSIDES
947Stomatocytes presentOFFSIDES
948Streptococcal Infections2306432CTD
949StrongyloidiasisOFFSIDES
950StuporCanada Vigilance: 1Canada Vigilance
951Subcutaneous noduleOFFSIDES
952SubileusOFFSIDES
953Superficial ThrombophlebitisOFFSIDES
954SweatingSIDER
955Synovial CystOFFSIDES
956SynovitisOFFSIDES
957Taste Disorders

View details

CTD
SIDER
958TendinitisOFFSIDES
959TenosynovitisOFFSIDES
960Testicular Diseases1288759CTD
961Therapeutic procedureOFFSIDES
962Therapeutic product effect decreasedCanada Vigilance: 1Canada Vigilance
963ThrombophlebitisSIDER
964Thrombosis in deviceOFFSIDES
965ThymomaOFFSIDES
966ThyroidectomyOFFSIDES
967Tooth ExtractionOFFSIDES
968Tooth InfectionOFFSIDES
969Tooth repairOFFSIDES
970Torsades de Pointes15869686CTD
971TorticollisCanada Vigilance: 1Canada Vigilance
972Traumatic liver injurySIDER
973Trichomonas Infections842719CTD
974Trichomonas Vaginitis3992315
23478970
CTD
975Tricuspid Valve ProlapseOFFSIDES
976Urine cytomegalovirus positiveOFFSIDES
977Urine output increasedSIDER
978Uterine CancerOFFSIDES
979Uterine spasmOFFSIDES
980Vaginal drynessSIDER
981Vaginal mycosisSIDER
982Vaginitis5789554
16230824
16901452
CTD
983Vascular calcificationOFFSIDES
984Venous InsufficiencyOFFSIDES
985Vision Disorders17760644CTD
986Vulvovaginal drynessSIDER
987Weaning failureOFFSIDES
988Wheelchair userOFFSIDES
989Wound closureOFFSIDES
990Wound dehiscenceOFFSIDES
991Yeast infectionSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120141

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.